Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Assess the Efficacy and Safety of Induction Therapy With LYC-30937-EC in Subjects With Active Ulcerative Colitis
Conditions
Interventions
LYC-30937-EC
Placebo
Locations
71
United States
Lycera Investigational Site
Little Rock, Arkansas, United States
Lycera Investigational Site
Long Beach, California, United States
Lycera Investigational Site
Mission Hills, California, United States
Lycera Investigational Site
Rialto, California, United States
Lycera Investigational Site
Hollywood, Florida, United States
Lycera Investigational Site
Miami, Florida, United States
Start Date
July 1, 2016
Primary Completion Date
May 1, 2018
Completion Date
May 1, 2018
Last Updated
April 2, 2019
NCT06294925
NCT05076175
NCT06359808
NCT06651281
NCT04121806
NCT06065228
Lead Sponsor
Lycera Corp.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions